In this article, we will discuss 11 Best Low Priced Growth Stocks to Buy Right Now.

Low-priced growth stocks, specifically those combining a low forward P/E ratio with strong or accelerating Earnings Per Share (EPS), offer a compelling blend of value and momentum. A low forward P/E suggests investors are paying a relatively modest price for each dollar of expected future earnings, potentially signaling undervaluation or overly cautious market expectations. At the same time, high or rapidly growing EPS indicates that the company is generating substantial profits and improving its operational efficiency. When these two characteristics align, investors gain exposure to businesses that are not only expanding earnings but are also trading at reasonable (or even discounted) valuations.

This combination can create a powerful setup for outperformance. If earnings continue to grow as projected, the stock benefits from fundamental profit expansion. If the market reassesses the company’s prospects more positively, the valuation multiple may also expand, delivering an additional layer of upside. In other words, investors may capture both earnings growth and multiple re-rating. Furthermore, strong EPS provides flexibility for reinvestment, debt reduction, or dividend growth, reinforcing financial stability while supporting long-term shareholder returns.

By focusing on companies that exhibit both growth and valuation discipline, investors position themselves to benefit from improving fundamentals without overpaying for future potential, an approach that balances opportunity with margin of safety.

With this context in mind, here is a list of the 11 best low priced growth stocks to buy right now.

Our Methodology

We used screeners to identify stocks that have a track record of delivering earnings growth and have grown their EPS by at least 20% over the past 3 years. From this pool, we focused on equities that are trading at a forward P/E of less than 15 and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. We ranked these stocks in ascending order of their forward P/E. These stocks are also popular among analysts and elite hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

11 Best Low Priced Growth Stocks to Buy Right Now

11. Vital Farms, Inc. (NASDAQ:VITL)

EPS Growth in 3 years: 176.28%

Forward P/E: 14.28

On February 26, Benchmark downgraded Vital Farms, Inc. (NASDAQ:VITL) to Hold from Buy and removed its price target following the company’s issuance of what the firm characterized as a “volatile” Q1 outlook. Benchmark cited tempered FY26 revenue growth expectations and guidance for sharp margin compression as drivers of increased uncertainty. While the firm remains highly convinced in the long-term strength of Vital Farms’ brand and revenue growth trajectory, it believes near-term margin pressure and diminished credibility outweigh the positives at present, suggesting the situation may require several quarters to stabilize.

That same day, Vital Farms, Inc. (NASDAQ:VITL) reported Q4 revenue of $213.55 million, modestly ahead of consensus estimates of $212.83 million. Management stated that 2025 marked a pivotal year in scaling the company’s supply chain to meet demand. The expansion of Egg Central Station and the growth of its farmer network to over 600 small farms significantly reduced prior supply constraints that had limited growth. These operational investments enhanced production capacity and positioned the company for improved demand fulfillment, though near-term profitability remains under pressure.

Additionally, Vital Farms, Inc. (NASDAQ:VITL) announced an orderly transition in board leadership. Founder Matt O’Hayer stepped down as executive chairperson and board member effective February 24, transitioning to a non-employee advisory role. The board appointed President and CEO Russell Diez-Canseco to serve as executive chairperson, consolidating leadership responsibilities as the company navigates its next operational phase.

Vital Farms, founded in 2007 and headquartered in Austin, Texas, is a leading U.S. food company specializing in ethically produced, pasture-raised eggs and butter. Partnering with hundreds of small family farms nationwide, the company emphasizes animal welfare standards while distributing responsibly sourced products across major U.S. retail channels.

10. Salesforce, Inc. (NYSE:CRM)

EPS Growth in 3 years: 234.40%

Forward P/E: 13.34

On February 26, Piper Sandler lowered the firm’s price target on Salesforce, Inc. (NYSE:CRM) to $250 from $280 and maintained an Overweight rating. The firm noted that Q4 results narrowly exceeded consensus expectations; however, initial FY27 revenue growth guidance of 10.5% year-over-year came in modestly below Street expectations of approximately 11.1%. With investors intensely focused on the broader debate around AI-driven disruption and competitive positioning, Piper believes the slightly softer guide alone is unlikely to materially shift investor sentiment. That said, management reaffirmed its September Analyst Day expectations, highlighting strong bookings trends and improvements in customer attrition that are driving net new annualized recurring revenue (NNAOV) growth to outpace overall average order value (AOV) growth.

The same day, RBC Capital lowered its price target on Salesforce to $210 from $290 and maintained a Sector Perform rating. RBC described the quarter as decent overall, with revenue largely in line with consensus and Agentforce showing early signs of traction. However, the firm views the shares as “fully valued” at current levels and emphasized that the softer-than-expected forward guidance tempers enthusiasm. According to RBC, while AI product momentum remains an area of potential upside, the combination of valuation and moderated growth expectations supports a more balanced risk-reward outlook in the near term.

Founded in 1999 and headquartered in San Francisco, California, Salesforce provides a cloud-based customer relationship management platform designed to unify sales, service, marketing, and commerce functions. The company increasingly embeds AI and automation capabilities into its ecosystem to streamline workflows and enhance enterprise productivity across organizations of all sizes.